| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N-acetyllactosamine synthase activity | 6.36e-05 | 5 | 51 | 2 | GO:0003945 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 2.17e-05 | 3 | 56 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 2.17e-05 | 3 | 56 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.17e-05 | 3 | 56 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 4.33e-05 | 4 | 56 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 8.15e-05 | 387 | 56 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 9.26e-05 | 395 | 56 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 2.48e-04 | 45 | 56 | 3 | GO:0030866 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 2.57e-04 | 9 | 56 | 2 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 2.57e-04 | 9 | 56 | 2 | GO:0000912 | |
| Domain | RasGAP_C | 2.19e-05 | 3 | 51 | 2 | IPR000593 | |
| Domain | RasGAP_C | 2.19e-05 | 3 | 51 | 2 | PF03836 | |
| Domain | LRRNT | 1.47e-04 | 98 | 51 | 4 | IPR000372 | |
| Domain | LRRNT | 1.47e-04 | 98 | 51 | 4 | SM00013 | |
| Domain | Galactosyl_T | 1.52e-04 | 7 | 51 | 2 | IPR003859 | |
| Domain | Glyco_transf_7C | 1.52e-04 | 7 | 51 | 2 | PF02709 | |
| Domain | Glyco_transf_7N | 1.52e-04 | 7 | 51 | 2 | PF13733 | |
| Domain | Galactosyl_T_C | 1.52e-04 | 7 | 51 | 2 | IPR027791 | |
| Domain | Galactosyl_T_N | 1.52e-04 | 7 | 51 | 2 | IPR027995 | |
| Domain | LRR | 2.16e-04 | 201 | 51 | 5 | PS51450 | |
| Domain | LRRNT | 4.08e-04 | 53 | 51 | 3 | PF01462 | |
| Domain | RasGAP | 6.51e-04 | 14 | 51 | 2 | SM00323 | |
| Domain | RasGAP_CS | 6.51e-04 | 14 | 51 | 2 | IPR023152 | |
| Domain | RasGAP | 7.50e-04 | 15 | 51 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 7.50e-04 | 15 | 51 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 7.50e-04 | 15 | 51 | 2 | PS50018 | |
| Domain | Leu-rich_rpt | 8.44e-04 | 271 | 51 | 5 | IPR001611 | |
| Domain | - | 8.56e-04 | 16 | 51 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 1.09e-03 | 18 | 51 | 2 | IPR001936 | |
| Domain | LRR_8 | 1.21e-03 | 171 | 51 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.38e-03 | 177 | 51 | 4 | IPR003591 | |
| Domain | LRR_TYP | 1.38e-03 | 177 | 51 | 4 | SM00369 | |
| Domain | Quino_amine_DH_bsu | 1.63e-03 | 22 | 51 | 2 | IPR011044 | |
| Domain | - | 1.79e-03 | 321 | 51 | 5 | 3.80.10.10 | |
| Domain | Cys-rich_flank_reg_C | 1.91e-03 | 90 | 51 | 3 | IPR000483 | |
| Domain | LRRCT | 1.91e-03 | 90 | 51 | 3 | SM00082 | |
| Domain | L_dom-like | 1.96e-03 | 328 | 51 | 5 | IPR032675 | |
| Domain | LRR_1 | 2.99e-03 | 219 | 51 | 4 | PF00560 | |
| Domain | LAM_G_DOMAIN | 4.83e-03 | 38 | 51 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 5.34e-03 | 40 | 51 | 2 | PF02210 | |
| Domain | LamG | 6.43e-03 | 44 | 51 | 2 | SM00282 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 6.11e-05 | 28 | 39 | 3 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 6.11e-05 | 28 | 39 | 3 | MM14798 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 1.31e-04 | 36 | 39 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 1.31e-04 | 36 | 39 | 3 | MM14632 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS | 1.55e-04 | 7 | 39 | 2 | M47965 | |
| Pathway | KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS | 1.55e-04 | 7 | 39 | 2 | M47968 | |
| Pathway | WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM | 4.04e-04 | 11 | 39 | 2 | M48314 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE | 7.65e-04 | 15 | 39 | 2 | M3042 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 7.65e-04 | 15 | 39 | 2 | M966 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 7.65e-04 | 15 | 39 | 2 | MM15700 | |
| Pubmed | XRN2 WDR36 POLR1A MYCBP2 WDR6 UBR4 EIF3E CCT2 MSH2 ECPAS TP53BP1 | 6.51e-09 | 653 | 56 | 11 | 22586326 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIFBP XRN2 POLR1A IQGAP2 UBE3A UBR4 UBE2M MSH2 IQGAP3 TP53BP1 | 1.67e-07 | 704 | 56 | 10 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 XRN2 WDR36 POLR1A MYCBP2 UBE3A WDR6 UBR4 EIF3E CCT2 UBE2M MSH2 TP53BP1 | 1.75e-07 | 1353 | 56 | 13 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP36 KIFBP XRN2 WDR36 POLR1A WDR6 UBR4 EIF3E CCT2 UBE2M MSH2 ECPAS IQGAP3 | 3.17e-07 | 1425 | 56 | 13 | 30948266 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | XRN2 POLR1A IQGAP2 MYCBP2 UBE3A WDR6 UBR4 EIF3E CCT2 MSH2 PIPSL IQGAP3 | 6.05e-07 | 1257 | 56 | 12 | 37317656 |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 35279875 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 29073199 | ||
| Pubmed | Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice. | 2.55e-06 | 2 | 56 | 2 | 37901252 | |
| Pubmed | 4.48e-06 | 1014 | 56 | 10 | 32416067 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 5.33e-06 | 807 | 56 | 9 | 30575818 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25722290 | ||
| Pubmed | Structure of Slitrk2-PTPδ complex reveals mechanisms for splicing-dependent trans-synaptic adhesion. | 7.63e-06 | 3 | 56 | 2 | 25989451 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22493426 | ||
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 7.63e-06 | 3 | 56 | 2 | 25229330 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 11588157 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 20697158 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.11e-05 | 85 | 56 | 4 | 16051665 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 28970065 | ||
| Pubmed | KIFBP XRN2 WDR36 IQGAP2 WDR6 UBR4 EIF3E RNF213 CCT2 MSH2 ECPAS | 1.58e-05 | 1440 | 56 | 11 | 30833792 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.72e-05 | 95 | 56 | 4 | 29643511 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.83e-05 | 341 | 56 | 6 | 32971831 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.38e-05 | 212 | 56 | 5 | 33853758 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.79e-05 | 759 | 56 | 8 | 35915203 | |
| Pubmed | 3.30e-05 | 777 | 56 | 8 | 35844135 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 3.44e-05 | 1284 | 56 | 10 | 17353931 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 3.50e-05 | 569 | 56 | 7 | 30639242 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 14557068 | ||
| Pubmed | The expanding beta 4-galactosyltransferase gene family: messages from the databanks. | 3.80e-05 | 6 | 56 | 2 | 9597550 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 14550773 | ||
| Pubmed | Differential expression of Slitrk family members in the mouse nervous system. | 3.80e-05 | 6 | 56 | 2 | 19924824 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 21299499 | ||
| Pubmed | Novel locus including FGF21 is associated with dietary macronutrient intake. | 3.80e-05 | 6 | 56 | 2 | 23372041 | |
| Pubmed | 4.04e-05 | 41 | 56 | 3 | 32723828 | ||
| Pubmed | 4.31e-05 | 120 | 56 | 4 | 27320910 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ROCK2 KIFBP XRN2 IQGAP2 MYCBP2 PTPRQ EIF3E MSH2 IQGAP3 TP53BP1 | 4.38e-05 | 1321 | 56 | 10 | 27173435 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.45e-05 | 400 | 56 | 6 | 35013556 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 23345436 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 18565761 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 5.83e-05 | 1367 | 56 | 10 | 32687490 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 18483556 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.54e-05 | 440 | 56 | 6 | 34244565 | |
| Pubmed | 7.77e-05 | 878 | 56 | 8 | 37223481 | ||
| Pubmed | 8.76e-05 | 144 | 56 | 4 | 35681168 | ||
| Pubmed | 1.02e-04 | 288 | 56 | 5 | 23383273 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.11e-04 | 153 | 56 | 4 | 26365490 | |
| Pubmed | Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors. | 1.14e-04 | 10 | 56 | 2 | 36109631 | |
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 38636522 | ||
| Pubmed | 1.25e-04 | 483 | 56 | 6 | 36912080 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 12220626 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.48e-04 | 498 | 56 | 6 | 36634849 | |
| Pubmed | IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. | 1.66e-04 | 12 | 56 | 2 | 18604197 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 1.68e-04 | 66 | 56 | 3 | 24811749 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.94e-04 | 331 | 56 | 5 | 19490893 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.97e-04 | 1005 | 56 | 8 | 19615732 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.97e-04 | 332 | 56 | 5 | 32786267 | |
| Pubmed | Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC. | 2.29e-04 | 14 | 56 | 2 | 22354037 | |
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 2.52e-04 | 350 | 56 | 5 | 26549023 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 2.58e-04 | 552 | 56 | 6 | 10737800 | |
| Pubmed | 2.76e-04 | 78 | 56 | 3 | 27114451 | ||
| Pubmed | 3.01e-04 | 16 | 56 | 2 | 10580128 | ||
| Pubmed | 3.01e-04 | 16 | 56 | 2 | 17567809 | ||
| Pubmed | 3.09e-04 | 81 | 56 | 3 | 12838346 | ||
| Pubmed | 3.09e-04 | 809 | 56 | 7 | 32129710 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.42e-04 | 582 | 56 | 6 | 20467437 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.58e-04 | 208 | 56 | 4 | 33230847 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 3.78e-04 | 211 | 56 | 4 | 17314511 | |
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 3.83e-04 | 18 | 56 | 2 | 11149944 | |
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 19961560 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 4.07e-04 | 89 | 56 | 3 | 27034005 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 4.07e-04 | 847 | 56 | 7 | 35235311 | |
| Pubmed | 4.16e-04 | 604 | 56 | 6 | 38803224 | ||
| Pubmed | Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. | 4.28e-04 | 19 | 56 | 2 | 21060863 | |
| Pubmed | Autoregulation of the 26S proteasome by in situ ubiquitination. | 4.28e-04 | 19 | 56 | 2 | 24743594 | |
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 34188037 | ||
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 9070936 | ||
| Pubmed | 4.32e-04 | 1429 | 56 | 9 | 35140242 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 4.50e-04 | 221 | 56 | 4 | 29991511 | |
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 25187374 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 4.82e-04 | 1149 | 56 | 8 | 35446349 | |
| Pubmed | 5.24e-04 | 21 | 56 | 2 | 37422473 | ||
| Pubmed | 5.24e-04 | 21 | 56 | 2 | 17403899 | ||
| Pubmed | 5.37e-04 | 1168 | 56 | 8 | 19946888 | ||
| Pubmed | 5.55e-04 | 638 | 56 | 6 | 33239621 | ||
| Pubmed | 5.65e-04 | 418 | 56 | 5 | 34709266 | ||
| Pubmed | 5.69e-04 | 641 | 56 | 6 | 36057605 | ||
| Pubmed | 5.76e-04 | 22 | 56 | 2 | 38736483 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 5.97e-04 | 647 | 56 | 6 | 26618866 | |
| Pubmed | 6.87e-04 | 24 | 56 | 2 | 31911859 | ||
| Pubmed | 7.46e-04 | 25 | 56 | 2 | 12522145 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 7.64e-04 | 942 | 56 | 7 | 31073040 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 8.19e-04 | 454 | 56 | 5 | 33226137 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 8.50e-04 | 262 | 56 | 4 | 36880596 | |
| Pubmed | 8.69e-04 | 963 | 56 | 7 | 28671696 | ||
| Pubmed | Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay. | 8.71e-04 | 27 | 56 | 2 | 30097011 | |
| Pubmed | Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. | 9.03e-04 | 117 | 56 | 3 | 34662580 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 9.28e-04 | 974 | 56 | 7 | 28675297 | |
| Pubmed | 9.37e-04 | 28 | 56 | 2 | 35474067 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 9.63e-04 | 271 | 56 | 4 | 32433965 | |
| Pubmed | 9.74e-04 | 472 | 56 | 5 | 38943005 | ||
| Pubmed | 9.98e-04 | 1285 | 56 | 8 | 35914814 | ||
| Interaction | SIRT7 interactions | XRN2 WDR36 POLR1A MYCBP2 WDR6 UBR4 EIF3E CCT2 MSH2 ECPAS TP53BP1 | 2.98e-06 | 744 | 53 | 11 | int:SIRT7 |
| Interaction | SIRT6 interactions | FAT1 XRN2 WDR36 POLR1A MYCBP2 UBE3A WDR6 MSH2 IQGAP3 TP53BP1 | 4.68e-06 | 628 | 53 | 10 | int:SIRT6 |
| Interaction | ATP1A1 interactions | 1.70e-05 | 575 | 53 | 9 | int:ATP1A1 | |
| Interaction | POLR1G interactions | 3.85e-05 | 489 | 53 | 8 | int:POLR1G | |
| Interaction | GNB2 interactions | 4.64e-05 | 502 | 53 | 8 | int:GNB2 | |
| Interaction | PSMD4 interactions | 4.78e-05 | 368 | 53 | 7 | int:PSMD4 | |
| Interaction | RHOBTB1 interactions | 4.90e-05 | 152 | 53 | 5 | int:RHOBTB1 | |
| Interaction | UTP18 interactions | 4.90e-05 | 152 | 53 | 5 | int:UTP18 | |
| Interaction | AATF interactions | 5.48e-05 | 376 | 53 | 7 | int:AATF | |
| Interaction | GRWD1 interactions | 6.90e-05 | 390 | 53 | 7 | int:GRWD1 | |
| Interaction | BRCA1 interactions | USP2 XRN2 POLR1A UBE3A WDR6 UBR4 EIF3E CCT2 MSH2 ECPAS USH2A TP53BP1 | 7.58e-05 | 1249 | 53 | 12 | int:BRCA1 |
| Interaction | TRIM28 interactions | USP36 KIFBP XRN2 POLR1A IQGAP2 MYCBP2 UBE3A UBR4 CCT2 UBE2M MSH2 IQGAP3 TP53BP1 | 8.61e-05 | 1474 | 53 | 13 | int:TRIM28 |
| Interaction | TUBB4B interactions | 9.96e-05 | 560 | 53 | 8 | int:TUBB4B | |
| Interaction | C9orf72 interactions | XRN2 POLR1A IQGAP2 MYCBP2 UBE3A WDR6 UBR4 EIF3E CCT2 MSH2 PIPSL IQGAP3 | 1.27e-04 | 1319 | 53 | 12 | int:C9orf72 |
| Interaction | RANGAP1 interactions | 1.69e-04 | 314 | 53 | 6 | int:RANGAP1 | |
| Interaction | NSUN2 interactions | 1.97e-04 | 323 | 53 | 6 | int:NSUN2 | |
| Interaction | UTP15 interactions | 2.00e-04 | 110 | 53 | 4 | int:UTP15 | |
| Interaction | BBS1 interactions | 2.07e-04 | 111 | 53 | 4 | int:BBS1 | |
| Interaction | PSMD12 interactions | 2.25e-04 | 331 | 53 | 6 | int:PSMD12 | |
| Interaction | UBE2L3 interactions | 2.29e-04 | 211 | 53 | 5 | int:UBE2L3 | |
| Cytoband | 17q25.3 | 2.63e-04 | 101 | 56 | 3 | 17q25.3 | |
| Cytoband | 19q13.33 | 3.03e-04 | 106 | 56 | 3 | 19q13.33 | |
| Cytoband | Xq27.3 | 9.47e-04 | 37 | 56 | 2 | Xq27.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 5.35e-03 | 89 | 56 | 2 | chr7p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq27 | 5.58e-03 | 91 | 56 | 2 | chrXq27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 6.32e-03 | 307 | 56 | 3 | chr17q25 | |
| GeneFamily | Beta 4-glycosyltransferases | 5.44e-04 | 17 | 37 | 2 | 425 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 184 | 56 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 184 | 56 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 184 | 56 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.89e-06 | 177 | 56 | 5 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.59e-06 | 185 | 56 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 3.98e-06 | 189 | 56 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.33e-05 | 44 | 56 | 3 | 2aa44b57544d5264db5b265ae60f7460c5b2a217 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.33e-05 | 155 | 56 | 4 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 160 | 56 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.39e-05 | 164 | 56 | 4 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 5.65e-05 | 166 | 56 | 4 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 176 | 56 | 4 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.55e-05 | 65 | 56 | 3 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.55e-05 | 65 | 56 | 3 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 8.25e-05 | 183 | 56 | 4 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.78e-05 | 186 | 56 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.73e-05 | 191 | 56 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-04 | 193 | 56 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 195 | 56 | 4 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 197 | 56 | 4 | 1ca06d6d288cb58a6e8062ebc01831e58ee5be4b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 197 | 56 | 4 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.12e-04 | 198 | 56 | 4 | bfad1c51cf884ff7ce89f8278820800582541dc7 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.12e-04 | 198 | 56 | 4 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.12e-04 | 198 | 56 | 4 | 6372e65242236c497d9b3be147092897c1609d22 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 1.12e-04 | 198 | 56 | 4 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 1.14e-04 | 199 | 56 | 4 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 56 | 4 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 1.14e-04 | 199 | 56 | 4 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 56 | 4 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 56 | 4 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 3a954d9d542e52c9b181f0850a09b1bff0a0c82d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| Disease | protein intake measurement | 1.36e-04 | 10 | 52 | 2 | EFO_0010810 | |
| Disease | retinal vasculature measurement | 2.89e-04 | 517 | 52 | 6 | EFO_0010554 | |
| Disease | suicidal ideation | 1.20e-03 | 29 | 52 | 2 | EFO_0004320 | |
| Disease | carbohydrate intake measurement | 1.65e-03 | 34 | 52 | 2 | EFO_0010811 | |
| Disease | ovarian neoplasm | 1.72e-03 | 134 | 52 | 3 | C0919267 | |
| Disease | PR interval | 1.77e-03 | 495 | 52 | 5 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPFLQRQQLAYGIYV | 146 | O60512 | |
| IQNFYLPQNYIDQFL | 26 | Q9HC47 | |
| PFLQRQQLDYGIYVI | 146 | O60513 | |
| IQNLQPQYQFRDYFI | 321 | P00736 | |
| APSNRPYFLLLQGYQ | 376 | Q5U651 | |
| QFLQLYYSLLQENLP | 156 | P51959 | |
| RQRFNLNQYLPNFYP | 4481 | Q14517 | |
| YAPQNLSIRGEYQIN | 14191 | Q8WXI7 | |
| EPLLARQLYYFAQQN | 406 | Q15306 | |
| RYSNAQILQFQNPGY | 521 | A4FU01 | |
| RLYRYQFDPNLGIRQ | 1126 | Q5VYK3 | |
| PLLQFGGQVRQRYLY | 36 | Q9NSA1 | |
| IYYVFERLPQNGQLQ | 1311 | Q5H8C1 | |
| NPQLSFYQLVYGLNA | 856 | Q96J66 | |
| VGNLLYYRFLNPAVV | 1171 | Q86VI3 | |
| NLYLQYNQVSFVPRG | 136 | Q7Z2Q7 | |
| PGYYINLNQNPRTLL | 156 | A2A3N6 | |
| QPNGNIQVYQALVYR | 1711 | Q9UMZ3 | |
| INYLGEYLIRNNPNY | 211 | A4FU69 | |
| PLIRNQLVNYIYNGF | 301 | Q05DH4 | |
| QLVNYIYNGFLVPVL | 306 | Q05DH4 | |
| LVGQYSLRKQPYNNL | 271 | Q15131 | |
| QGERIYRKFQYLLNP | 451 | Q9Y6T7 | |
| NIIDLFLYQPQYLNA | 231 | P60228 | |
| YNYIFNPVLQRGVEL | 731 | Q99698 | |
| NLYQRRPAIAINNPY | 61 | P07498 | |
| LQDCYRLYQGINQLP | 401 | P43246 | |
| LNPQYYLLVNRQIQF | 461 | Q96EK5 | |
| QNPLCQYNLYRLYII | 146 | A6NJI9 | |
| FYIPRNLEHLYLQNN | 296 | Q99983 | |
| YLNGNQIERLYPEIF | 431 | Q8IW52 | |
| QSNGPIIYYILLRNG | 3526 | O75445 | |
| QLRFQFLPHAYYQQE | 1316 | O95602 | |
| LNKQVYGPFYANILR | 486 | Q8N4U5 | |
| YNPAQQILAYAGFRL | 241 | Q8WV15 | |
| QQLFYLLQTNPLYLA | 886 | Q13576 | |
| PGFDQRLLLYQLFNY | 271 | Q9H479 | |
| LLQPPQYRIYQLFLN | 56 | Q9H156 | |
| GNLLTRLYPNEFVNY | 71 | Q9H156 | |
| GINCFINRQLIYNYP | 286 | P78371 | |
| INRQLIYNYPEQLFG | 291 | P78371 | |
| NQTRGQIPQILYYRS | 1871 | O75592 | |
| RPYQYLRRFNQNQDL | 2166 | Q63HN8 | |
| YSLVQGQQLNPYLRL | 511 | Q05086 | |
| YYNNDLLRNRFIGLQ | 641 | O94956 | |
| YQGNLYRPLLRGQAQ | 841 | Q9H0D6 | |
| NQLPFIGFTYYRENL | 406 | O75116 | |
| HANQLQNYRNYLLPA | 1836 | Q12888 | |
| QALGQGPQFIFQYYR | 56 | A0A0C4DH59 | |
| YYQLFVRDGQLQPVL | 591 | Q9NNW5 | |
| VQYPNRGLQFLLKYI | 56 | A0A0B4J244 | |
| TQIQRYAPRFVGYNQ | 341 | O75604 | |
| LNLPYFLRYINRFQD | 261 | Q5T4S7 | |
| NSIIYGLQYLFLEPN | 126 | P61081 | |
| VFYRPYLQIFGQIPQ | 966 | Q8TD43 | |
| LNQQAYVLFYLRIPG | 411 | Q9P275 | |
| LYQYYLAQNMNLPNL | 861 | Q15911 | |
| PLTNIRYYGQNGQQI | 381 | Q8NI36 | |
| DNPNLVIRIYNRYYN | 506 | Q92539 |